At Abiomed's European headquarters in Aachen, Germany, Impella heart pumps have been developed and produced for more than 20 years to stabilize and recover the human heart. The single access procedure ...

HACKENSACK, N.J., Oct. 28, 2019 /PRNewswire/ -- On October 16, 2019, Hackensack Meridian Health's Hackensack University Medical Center performed its first cardiovascular surgery procedures using a new ...

Bundang Seoul National University Hospital announced that the cardiovascular intervention team led by Professor Chae In-ho of ...

Over 3,000 U.S. Patients Have Received Higher Flow Impella CP DANVERS, Mass., (GLOBE NEWSWIRE) -- Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported that ...

MERIDIAN, Miss. — Patients in Mississippi previously turned away for heart surgery may have another option in the Impella 2.5, the world's smallest heart pump — now available for elderly, unstable or ...

The Heart Hospital of Northwest Texas Healthcare System has been recognized by Abiomed for its achievement of 200 Impella procedures, according to a news release. This life-changing procedure has ...

Compared with no added support, use of the Impella percutaneous left ventricular assist device (Abiomed) in patients undergoing high-risk nonemergent PCI is associated with more periprocedural MI ...

A pricey high-tech pump that maintains blood flow during heart procedures could be more dangerous to patients than its low-tech predecessor, a pair of recent studies finds. The Impella device is ...

PHILADELPHIA — Interventional cardiology has taken quite a shine to Impella ventricular assist pumps (Abiomed) for cardiogenic shock (CS) and to support high-risk procedures, but two new observational ...

Abiomed (NASDAQ: ABMD) struggled in 2019, but the stock has risen more than 62% so far this year. The question for most investors is how long that trend can continue for the medical device maker.

AACHEN, Germany--(BUSINESS WIRE)--Following consultation with its notified body, MEDCERT GmbH, Abiomed is introducing the single access procedure with Impella CP introducer sheaths for the treatment ...

Shares have risen more than 62% year to date. Is the medical device company still a good buy? Abiomed's devices all have to do with the circulatory system, including the world's smallest heart pump, ...